Pentraxin 3: A Biomarker Link between Inflammation and Cardiovascular Risk among Obese Children

Dervisoglu, P., & Elmas, B. (2021). Pentraxin 3 as a Marker for Cardiovascular Disease Risk in Overweight and Obese Children. Acta Cardiologica Sinica, 37(2), 177-183. https://doi.org/10.6515/ACS.202103_37(2).20201006A
吳德敏、申慕韓、楊士賢、王淑娟、孫建安、楊燦、祝年豐（2005）。Aggregation of Cardiovascular Disease Risk Factors in Young Obese Men-An Example from Health check-up Population。中華職業醫學雜誌，12(4)，215-227。https://doi.org/10.30027/CJOM.200510.0002
Aygun, A. D., Gungor, S., Ustundag, B., Gurgoze, M. K., & Sen, Y. (2005). Proinflammatory Cytokines and Leptin Are Increased in Serum of Prepubertal Obese Children. Mediators of Inflammation, 2005(), 180-183. https://doi.org/10.1155/MI.2005.180
Slusher, A. L., Huang, C. J., & Acevedo, E. O. (2017). The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation. Mediators of Inflammation, 2017(), 1-9. https://doi.org/10.1155/2017/1092738
Montecucco, F., Mach, F., Pende, A., Schindler, T. H., Silva, R. F. D., & Vuilleumier, N. (2012). Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations. Mediators of Inflammation, 2012(), 48-50-104. https://doi.org/10.1155/2012/515692